|
CNBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.81980003183457E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17117426867708E-12 |
| Normal-vs-Stage2 |
2.580500E-04 |
| Normal-vs-Stage3 |
1.258830E-03 |
| Normal-vs-Stage4 |
4.910600E-01 |
| Stage1-vs-Stage2 |
4.609200E-01 |
| Stage1-vs-Stage3 |
8.089500E-02 |
| Stage1-vs-Stage4 |
3.482800E-01 |
| Stage2-vs-Stage3 |
5.080400E-01 |
| Stage2-vs-Stage4 |
5.018400E-01 |
| Stage3-vs-Stage4 |
6.842800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.86900536450707E-11 |
| Normal-vs-AfricanAmerican |
4.27909999656251E-08 |
| Normal-vs-Asian |
2.217800E-04 |
| Caucasian-vs-AfricanAmerican |
9.540400E-01 |
| Caucasian-vs-Asian |
7.209200E-01 |
| AfricanAmerican-vs-Asian |
6.882800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.10740322362335E-12 |
| Normal-vs-Female |
2.157200E-04 |
| Male-vs-Female |
8.084200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.774400E-04 |
| Normal-vs-Extreme_Weight |
2.00290006802106E-10 |
| Normal-vs-Obese |
2.14049999947008E-08 |
| Normal-vs-Extreme_Obese |
7.573600E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.856400E-01 |
| Normal_Weight-vs-Obese |
9.917200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.788600E-01 |
| Extreme_Weight-vs-Obese |
4.060400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.335000E-01 |
| Obese-vs-Extreme_Obese |
8.805500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.603000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.55320003922566E-09 |
| Normal-vs-Age(61-80Yrs) |
7.2348793622723E-12 |
| Normal-vs-Age(81-100Yrs) |
2.411800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.719000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.896160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.078000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.314800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.898400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.421600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.21539461722864E-11 |
| Normal-VS-Type2 PRCC |
2.82830425746283E-11 |
| Normal-VS-KIRP CIMP |
4.308800E-01 |
| Normal-VS-Unclassified PRCC |
1.33639999955193E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.497600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.079500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.835000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.210300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.990000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.218400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.32380822654477E-12 |
| Normal-vs-N1 |
8.042000E-02 |
| Normal-vs-N2 |
9.350800E-01 |
| N0-vs-N1 |
9.83519999999682E-05 |
| N0-vs-N2 |
4.736000E-01 |
| N1-vs-N2 |
7.831600E-01 |
|
|
